Trial Profile
Tolerability and pharmacokinetics of sugammadex in Chinese volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Oct 2015
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Adverse reactions; Pharmacokinetics
- 18 Nov 2013 New trial record